跳至主要内容
临床试验/NCT00733213
NCT00733213已完成不适用

Depiction of Prostate Cancer Treatment Alternatives in Greece

AstraZeneca1 个研究点 分布在 1 个国家目标入组 310 人开始时间: 2008年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
310
试验地点
1
主要终点
Percentage of patients treated by each treatment alternative.

研究概览

简要总结

A retrospective, registry analysis of the socio-economic and demographic characteristics of patients suffering from locally advanced or metastatic prostate cancer, as well as the depiction of the therapeutic algorithms followed in the Greek clinical practice.

  • Target Group: Patients with locally advanced or metastatic prostate cancer.
  • The first 10 consecutive patients records that meet the entry criteria.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Patients diagnosed with Locally advanced or Metastatic Prostate Cancer after
  • Patients that received Hormonal therapy.

排除标准

  • Males that are aged less than 18 years

结局指标

主要结局

Percentage of patients treated by each treatment alternative.

时间窗: Between 2002 - 2008

次要结局

  • To depict sociodemographic characteristics and comorbidities.(Between 2002 - 2008)

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验